sector medic suppli devic
assum volum recoveri
messag ew report solid result difficult backdrop tavr
sale grew yoy total revenu cc top reduc
consensu estim impact elect procedur delay weigh
result final week believ edward weather storm fairli
well line result work suggest
cardio procedur hold better mani categori look ahead
manag also provid updat outlook revenu expect come
assum return normal procedur activ bracket
forecast come print
edward busi demonstr resili revenu cc
came consensu growth slow cc procedur volum
fell sharpli march across valv segment post-surg hemodynam
support portfolio prior viru mitig effort kick howev momentum edward
carri appear continu world-wide tavr revenu rose
cc beat tavr sale rose top reduc street
estim manag note acceler growth saw
follow low risk label expans continu earli march procedur began
postpon meanwhil ou tavr sale grew cc strength japan
off-set abrupt drop-off european procedur activ late quarter manag
expect japan pressur europ like
follow trajectori edward updat guidanc call tavr sale
flat underli basi rang assum procedur volum
bottom gradual recov return pre-covid level
model call edward post ww tavr sale cc year
market grow ex-fx
rest edward portfolio larg under-perform surgic structur
heart revenu fell cc short consensu weak driven
continu pressur savr tavr cannib surgic market coupl
procedur declin final two week quarter meanwhil critic
system busi mix quarter revenu cc fall shi
consensu strong demand truwav dispos pressur monitor devic
enough off-set weak enhanc surgic recoveri platform full year
edward expect ssh revenu declin cc vs cc previous
sale project yoy vs
final transcathet mitral tricuspid therapi revenu line
expect driven acceler pascal adopt europ despit decent
perform manag lower full year tmtt forecast
procedur expect significantli impact viru mitig effort
pandem also forc edward suspend enrol assort tmtt
clinic trial visibl case abl resum still limit today
manag optimist result month delay program
incom statement cost contain drove outsiz ep beat edward
report gross margin yoy ahead consensu
sg spend rose yoy sale came street
expect expens increas yoy sale
consensu combin drove ebita margin yoy
higher street project final edward tax rate came vs
consensu take bottom line despit ep still came
ahead street
page analyst certif import disclosur
given quickli macro situat evolv expect investor
focus manag team forward outlook actual result quarter
unlik mani med-tech compani edward elect provid revis guidanc
call ep yoy sale
compar prior forecast respect
manag expect second quarter revenu come impli
yoy declin revenu outlook line model come
week assum cardio procedur would hold rel well among
first come back hospit abl begin perform case view
support result hospit roundtabl see surpris
edward ep forecast impli better cost contain assum
compani adjust depress sale trajectori expect much convers
around guidanc focu manag expect procedur volum
roughli line compani forecast period prior viru
outbreak edward explain outlook bake idea could pent-
demand patient treat today well possibl
patient may still hesit undergo surgeri assum second
wave fall although manag indic compani prepar oper
environ scenario play
adjust estim model call ep total
revenu cc compar prior forecast
respect project ep cc sale
stock ew share trade revis ep estim vs
large-cap med-tech averag believ compani abil weather current
crisi better mani peer alreadi mostli bake result maintain
page analyst certif import disclosur
believ edward one great med-tech success stori past
decad transform way valvular heart diseas treat process estim
world-wide tavr sale came cc edward
busi gener revenu cc work suggest tavr
market track reach sale next four year edward pois
primari beneficiari growth even competit increas howev
street expect tavr growth alreadi high wake low-risk label expans
stock trade signific premium peer ep vs dont
see risk/reward attract current level
edward share trade ep estim ebitda well
large-cap med-tech averag respect believ
edward best-in-class top-lin growth profil warrant premium multipl see
valuat fulli reflect base case scenario tavr adopt
compani growth potenti next year better upsid opportun
elsewher group view remain neutral rate
upsid risk rate fair valu estim includ tavr market growth
exce street expect edward defend leadership posit world-wide
tavr share better forecast tmtt pipelin provid compani
meaning new growth driver sooner anticip
downsid risk rate fair valu estim includ tavr market growth
fall short street expect greater-than-expect share gain new tavr
competitor come market clinic and/or regulatori setback pipelin
program caus investor question sustain edward premium growth
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
